Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SRNE > SEC Filings for SRNE > Form 8-K on 5-Aug-2013All Recent SEC Filings

Show all filings for SORRENTO THERAPEUTICS, INC.

Form 8-K for SORRENTO THERAPEUTICS, INC.


5-Aug-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On August 5, 2013, Sorrento Therapeutics, Inc. (the "Company") issued a press release announcing that IGDRASOL has received official meeting minutes from an End-of-Phase 2 meeting for Cynviloq™ with the U.S. Food and Drug Administration. A copy of the press release is attached hereto as Exhibit 99.1.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release issued August 5, 2013

  Add SRNE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SRNE - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.